Budesonide

Active ingredient description

Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Budesonide
A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07E Intestinal antiinflammatory agents → A07EA Corticosteroids acting locally
Discover more medicines within A07EA06
Budesonide
D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC09
Budesonide
R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids
Discover more medicines within R01AD05
Budesonide
R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA02

Medicines

Budesonide is the active ingredient of these drugs:

Drug
Countries

France

Tunisia

United Kingdom

Germany

Cyprus

United Kingdom

Tunisia

Hong Kong

Cyprus Hong Kong

Australia

Germany

Brazil

United Kingdom

Hong Kong Spain Tunisia

Hong Kong

Australia Cyprus Hong Kong Ireland Lithuania

Lithuania

Austria Germany Lithuania Singapore Tunisia

Austria

Brazil

Brazil

Austria Canada Cyprus France Hong Kong

Tunisia

Hong Kong

Spain

Austria Brazil Canada France Hong Kong

United States

Hong Kong Singapore

Cyprus Singapore

Lithuania Singapore

Brazil

Brazil

Spain

Austria Canada Ireland Lithuania Netherlands

Austria Brazil Cyprus Germany Spain

France

France

Brazil

Spain

France Germany

United States

Australia Austria Brazil Canada Cyprus

Canada France Germany Hong Kong Lithuania

Hong Kong

Spain

United States

Budesonide is also found within below combination drugs:

AIRBUFO , ALENIA , BIRESP SPIROMAX , BREZTRI , BUFAR EASYHALER , BUFOLER , BUFOMIX EASYHALER , BUFORI EASYHALER , BUSALAIR , COMBIFOR , DUORESP , ENTOCORT ENEMA , FOBUMIX , FORASEQ , GIBITER , PULMELIA , PULMOTON , RILAST , RILTRAVA AEROSPHERE , SYMBICORT , TRIXEO AEROSPHERE , VANNAIR , VYLAER SPIROMAX

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of product characteristics (SPC)
UK
Summary of product characteristics (SPC)
UK
Summary of product characteristics (SPC)
UK
Summary of product characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

Q3OKS62Q6X - BUDESONIDE

CAS registry number

51333-22-3 - budesonide

SNOMED-CT

395726003 - Budesonide (substance)